This article was originally published in The Gray Sheet
Signs contract -- worth an estimated $800 mil. over eight years -- with Columbia/HCA Healthcare to provide "products and services related to intravenous systems and diagnostic products." The agreement includes "innovative programs for reducing costs by standardizing many of the products and procedures used in Columbia/HCA's medical facilities, improving inventory management, reducing product waste and reengineering of medical processes," Baxter says
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.